Hasil Pencarian - Stephanie L. Gaillard

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinoma

    Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinoma oleh Joy M. Davis, Tullia Rushton, Felicity Nsiah, Rebecca L. Stone, Anna L. Beavis, Stéphanie L. Gaillard, Alice Dobi, Amanda N. Fader

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy

    Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy oleh Yao-An Shen, Jin Jung, Geoffrey D. Shimberg, Fang-Chi Hsu, Yohan Suryo Rahmanto, Stephanie L. Gaillard, Jiaxin Hong, Jürgen Bosch, Ie-Ming Shih, Chi-Mu Chuang, Tian-Li Wang

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer

    Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer oleh Alexandra N. Aquino-Acevedo, Hope Knochenhauer, Yesenia Castillo-Ocampo, Melanie Ortiz-León, Yadiel A. Rivera-López, Camily Morales-López, Melanie E. Cruz-Robles, Elvin R. Hernández-Cordero, Shonagh Russell, Regina Whitaker, Margarita Bonilla-Claudio, Dung-Tsa Chen, Julie Dutil, Stephanie L. Gaillard, John S. Yi, Rebecca A. Previs, Guillermo N. Armaiz-Pena

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer

    Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer oleh John Wright, Stephanie Lheureux, Ilaria Colombo, Ramy Gadalla, Pamela S Ohashi, Xuan Li, Lisa Wang, Matthew S Block, David G Brooks, Andrea Jewell, Carolyn McCourt, Eugenia Girda, Sarah Temkin, Gini F Fleming, Linda Duska, Daniela E Matei, Panagiotis A Konstantinopoulos, Ben X Wang, Stephanie L Gaillard, Michael McHale, Floor J Backes, Theresa L Werner, Siobhan Kehoe, Rachel Wildman, Shirin Soleimani, Scott Lien, Trevor Pugh

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: